Skip to main content

MAP3K8/Tpl2/COT Products

MAP3K8, also called Tpl2 (tumor progression locus 2) or COT (Cancer Osaka Thyroid oncogene), is a cytosolic Ser/Thr kinase. MAP3K8 is one of the MAP kinase kinase (MAPKK) kinases that regulates the ERK1/ERK2 pathway in response to IL-1, facilitating IL-8 and MIP-1 beta production. MAP3K8 activates I kappa B kinases and induces the nuclear production of NF-kappa B.

4 results for "MAP3K8/Tpl2/COT" in Products

MAP3K8/Tpl2/COT Products

MAP3K8, also called Tpl2 (tumor progression locus 2) or COT (Cancer Osaka Thyroid oncogene), is a cytosolic Ser/Thr kinase. MAP3K8 is one of the MAP kinase kinase (MAPKK) kinases that regulates the ERK1/ERK2 pathway in response to IL-1, facilitating IL-8 and MIP-1 beta production. MAP3K8 activates I kappa B kinases and induces the nuclear production of NF-kappa B.

4 results for "MAP3K8/Tpl2/COT" in Products

BA

Potent and selective Tpl2 (Cot; MAP3K8) inhibitor

Potent and selective Tpl2 (MAP3K8) inhibitor

Results Per Page
5 10 25 50
/ 1